No Data
wai yuen tong (00897): Xue Yongheng has been appointed as the Chairman of the Remuneration Committee.
Wai Yuen Tong (00897) announced that Mr. Siu Man-ho hopes to focus more on his own business activities, so Mr. Siu has resigned...
Do These 3 Checks Before Buying Wai Yuen Tong Medicine Holdings Limited (HKG:897) For Its Upcoming Dividend
WAI YUEN TONG: 2024 ANNUAL REPORT
Wai Yuen Tong Medicine Holdings Limited (HKG:897) Held Back By Insufficient Growth Even After Shares Climb 47%
Wai Yuen Tong Medicine's Losses Shrink in Fiscal Year 2024; Shares Surge 34%
Stock Market News: Wai Yuen Tong (00897) surged more than 52%, annual losses narrowed by 25%, and a final dividend and special dividend of 17.7 Hong Kong cents were declared.
Wai Yuen Tong (00897) surged more than 52% according to the Zhītōngcáijīng APP. As of publication, it increased by 52.26%, with volume of 2.1572 million Hong Kong dollars. In terms of news, Wai Yuen Tong released its annual results for the year ending March 31, 2024. The group achieved a revenue of 780 million Hong Kong dollars, an increase of 8.3% year-on-year, while the parent company's loss decreased by 25.15% to 15.356 million Hong Kong dollars. A final dividend of HK$0.03 per share and a special dividend of HK$0.147 per share are planned to be distributed. The company indicates that the reduced loss is mainly due to an increase in gross profit generated from the production and sale of pharmaceutical and health food products.
Investors Give Wai Yuen Tong Medicine Holdings Limited (HKG:897) Shares A 46% HidingNo Data
No Data
